Zevra Therapeutics Inc (NASDAQ:ZVRA) shares, rose in value, with the stock price up by 1.42% to the previous day’s close as strong demand from buyers drove the stock to $7.15.
Actively observing the price movement in the last trading, the stock closed the session at $7.05, falling within a range of $6.89 and $7.27. The value of beta (5-year monthly) was 1.94. Referring to stock’s 52-week performance, its high was $9.76, and the low was $4.20. On the whole, ZVRA has fluctuated by -10.06% over the past month.
With the market capitalization of Zevra Therapeutics Inc currently standing at about $386.93 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-10.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 85.06M, with a low estimate of 14.4M and a high estimate of 20.8M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 16.96M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ZVRA’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of ZVRA currently trading nearly -2.76% and -6.37% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 45.68, while the 7-day volatility ratio is showing 4.98% which for the 30-day chart, stands at 5.66%. Furthermore, Zevra Therapeutics Inc (ZVRA)’s beta value is 1.85, and its average true range (ATR) is 0.43.
A comparison of Zevra Therapeutics Inc (ZVRA) with its peers suggests the former has fared considerably weaker in the market. ZVRA showed an intraday change of 1.42% in last session, and over the past year, it grew by 49.43%%.
Data on historical trading for Zevra Therapeutics Inc (NASDAQ:ZVRA) indicates that the trading volumes over the past 10 days have averaged 0.57 and over the past 3 months, they’ve averaged 455.78K. According to company’s latest data on outstanding shares, there are 53.67 million shares outstanding.
Nearly 1.08% of Zevra Therapeutics Inc’s shares belong to company insiders and institutional investors own 62.87% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.91 million shares as on 2025-03-31, resulting in a short ratio of 11.59. According to the data, the short interest in Zevra Therapeutics Inc (ZVRA) stood at 1095.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 5.61 million. The stock has fallen by -14.27% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ZVRA stock heading into the next quarter.
